| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/26/2002 | CA2441673A1 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441279A1 Fluorescent polymer superquenching-based bioassays |
| 09/26/2002 | CA2441254A1 Examination device and method for examination of chemical and/or biological samples |
| 09/26/2002 | CA2441155A1 Methods of treating respiratory conditions |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/26/2002 | CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals |
| 09/26/2002 | CA2441021A1 Method for alteration detection |
| 09/26/2002 | CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | CA2440853A1 Phosphodiesterase 4d genes related to human stroke |
| 09/26/2002 | CA2440793A1 Predicting metabolic stability of drug molecules |
| 09/26/2002 | CA2440749A1 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | CA2440623A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related diseasestates |
| 09/26/2002 | CA2440584A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2438279A1 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | CA2437753A1 Multiplex protein interaction determinations using glutathione-gst binding |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
| 09/25/2002 | EP1244047A2 Method for providing clinical diagnostic services |
| 09/25/2002 | EP1243926A2 Diffusion-controlling sensor layer |
| 09/25/2002 | EP1243661A1 Method for reverse transcription |
| 09/25/2002 | EP1243659A1 Method for detecting target nucleotide sequences |
| 09/25/2002 | EP1243658A1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243646A2 Transgenic Drosophila with human APC gene for pharmacological screenings |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1242964A2 A method for the identification of gene transcripts with improved efficiency in the treatment of errors |
| 09/25/2002 | EP1242823A2 Selecting library members capable of binding to epitopes |
| 09/25/2002 | EP1242821A1 Direct screening method |
| 09/25/2002 | EP1242818A2 Method to evaluate the sensitivity of hiv variants to drugs able to inhibit the hiv protease |
| 09/25/2002 | EP1242814A2 Flow cell for synthesis of arrays of dna probes and the like |
| 09/25/2002 | EP1242634A2 Identification of virus-binding polypeptides and nucleotide sequences |
| 09/25/2002 | EP1242633A1 Nucleic acid amplification and detection of mycobacterium species |
| 09/25/2002 | EP1242632A2 Dna matrices and the use thereof for examining individuals of a population |
| 09/25/2002 | EP1242631A1 Multispecies food testing and characterization |
| 09/25/2002 | EP1242630A2 METHOD FOR GENERATING OLIGONUCLEOTIDES, IN PARTICULAR FOR THE DETECTION OF AMPLIFIED RESTRICTION FRAGMENTS OBTAINED USING AFLP$m(3) |
| 09/25/2002 | EP1242629A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 09/25/2002 | EP1242628A2 Method for analyzing nucleic acid sequences |
| 09/25/2002 | EP1242627A2 Method and device for detecting and quantifying biomolecules |
| 09/25/2002 | EP1242626A1 Detection of nucleic acids |
| 09/25/2002 | EP1242625A1 Probes and primers for the detection of polyphosphate accumulating organisms in wastewater |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242623A2 Methods for obtaining information about dna mixtures |
| 09/25/2002 | EP1242622A2 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 09/25/2002 | EP1242621A2 Primers, in particular, for primer-dependent nucleic acid synthesis processes and nucleic acid amplification methods |
| 09/25/2002 | EP1242620A2 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |
| 09/25/2002 | EP1242619A2 Assay for detection of human cftr allele variants using specific diagnostic primers |
| 09/25/2002 | EP1242618A2 DNA-based steganography |
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242616A2 Method for identification and quantification of kinase inhibitors |
| 09/25/2002 | EP1242615A2 Diagnostic analytical method and kit |
| 09/25/2002 | EP1242614A1 Measurement and control of sessile and planktonic microbiological activity in industrial water systems |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242606A2 Schizophrenia associated gene, proteins and biallelic markers |
| 09/25/2002 | EP1242601A1 Trichoderma reesei xylanase |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242599A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242594A1 Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
| 09/25/2002 | EP1242593A2 A functional gene array in yeast |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242586A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242577A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/25/2002 | EP1242576A1 Stabilizing diluent for polypeptides and antigens |
| 09/25/2002 | EP1242510A1 Particle structures with receptors for analyte detection |
| 09/25/2002 | EP1242459A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242457A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2002 | EP1242451A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 09/25/2002 | EP1242440A2 Use of nicotinamide adenine dinucleotide (nad) and nicotinamide adenine dinucleotide phosphate (nadp) analogs to measure enzyme activities, metabolites and substrates |
| 09/25/2002 | EP1242435A2 Medicaments for treatment of respiratory syncytial virus infections |
| 09/25/2002 | EP1242186A2 Integrated microfluidic disc |
| 09/25/2002 | EP1241934A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241933A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1189610A4 Method and markers for prognosticating efficacy of anticancer agents |
| 09/25/2002 | EP1179176A4 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 09/25/2002 | EP1082459A4 A novel method of diagnosing, monitoring, and staging lung cancer |
| 09/25/2002 | EP1066408A4 A novel method of detecting and monitoring endometrial and uterine cancers |
| 09/25/2002 | EP1060184A4 Best's macular dystrophy gene |
| 09/25/2002 | EP1049800A4 Asthma related genes |
| 09/25/2002 | EP0883393B1 Self-adhesive indicator |
| 09/25/2002 | EP0863998A4 Double-stranded conformational polymorphism analysis |
| 09/25/2002 | EP0794987B1 Chemiluminescent dialkyl-substituted 1,2-dioxetane compounds, methods of synthesis and use |
| 09/25/2002 | EP0775315B1 Method for separating and/or screening and/or quantifying one or more infectious compounds and support for implementing said method |
| 09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0695425B1 Surface amplifier |
| 09/25/2002 | CN1371428A Tryptophan synthease as site of herbicide action |
| 09/25/2002 | CN1371427A Method for identifying individual at risk for vascular and cancer disease |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371420A Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |